UBS Group’s DTRT Health Acquisition Corp. Unit DTRTU Stock Holding History

UBS Group’s Portfolio DTRTU Stock Details DTRTU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-499	Closed	-$5.14K	–	11442
2022 Q4	$5.14K	Sell	499 -100	-17%	-$1.03K	﹤0.01%	9214
2022 Q3	$6K	Hold	599	–	–	﹤0.01%	9138
2022 Q2	$6K	Buy	599 +5	+0.8%	+$50	﹤0.01%	8801
2022 Q1	$6K	Buy	594 +100	+20%	+$1.01K	﹤0.01%	9056
2021 Q4	$5K	Buy	494 +100	+25%	+$1.02K	﹤0.01%	9462
2021 Q3	$4K	Buy	+394	New	+$3.97K	﹤0.01%	8740

UBS Group's DTRTU Position: Q1 2023 in Review

UBS Group sold out of DTRT Health Acquisition Corp. Unit (DTRTU) in Q1 2023, closing a stake of 499 shares — an estimated $5.14K sold.

UBS Group first reported a position in DTRTU in Q3 2021 and held it in 6 quarters. The position peaked at $6K in Q3 2022. 0 funds tracked by Wall St. Rank hold DTRTU as of Q1 2023.

UBS Group reported no remaining DTRT Health Acquisition Corp. Unit position as of Q1 2023 after selling out during the quarter.
UBS Group sold 499 DTRT Health Acquisition Corp. Unit shares in Q1 2023, an estimated $5.14K.
UBS Group first reported a position in DTRT Health Acquisition Corp. Unit in Q3 2021 and held it in 6 quarters.
UBS Group's DTRT Health Acquisition Corp. Unit position peaked at $6K in Q3 2022.
0 funds tracked by Wall St. Rank held DTRT Health Acquisition Corp. Unit as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.